SEATTLE, WA– (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (Nasdaq: KDNY), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced the… Read More
Today, the U.S. Food and Drug Administration approved Aduhelm (aducanumab) for the treatment of Alzheimer’s, a debilitating disease affecting 6.2 million Americans. Aduhelm was approved using the accelerated approval pathway, which… Read More
EMPOWER Research is gathering information to help guide research towards novel rehabilitation treatments for anxiety, depression, and post-traumatic stress disorder (PTSD) for first responders and military personnel in Canada and… Read More
The province of BC is adding millions in additional funding to keep the Small and Medium-Sized Business Recovery Grant operating until the expected start of Step 3 of BC’s Restart… Read More
VICTORIA, BC (NEWS RELEASE) — Douglas magazine is proud to announce this year’s 10 to Watch winners, who represent the very best of Vancouver Island’s new businesses. From identifying faulty… Read More
